Mercilon

Desogestrel, the active ingredient in Mercilon, is a combined oral contraceptive presented as an oral tablet for oral use. It is used to prevent pregnancy in women of reproductive age by providing hormonal regulation that suppresses ovulation.

GNH USA supplies Mercilon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mercilon is a combined hormonal contraceptive indicated for use in the prevention of pregnancy and related menstrual regulation. - Prevention of pregnancy: provides reliable contraception by inhibiting ovulation. - Oral contraceptive use: offers a daily hormonal regimen for birth control. - Cycle regulation: helps achieve more predictable menstrual bleeding patterns.

Mercilon may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional throbbing or tension‑type pain. - Weight change: slight increase or decrease in body weight. - Mood changes: irritability or mild depressive symptoms. - Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke: cerebrovascular accident due to clot or hemorrhage. - Myocardial infarction: heart attack risk, especially in high‑risk groups. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzyme levels.

Before prescribing Mercilon, clinicians should evaluate individual risk factors and contraindications. - Contraindication in pregnancy: drug is contraindicated for pregnant women. - Cardiovascular risk assessment: avoid in smokers over 35 years or those with thromboembolic history. - Liver disease caution: use with care in patients with hepatic impairment. - Blood pressure monitoring: may cause slight elevation; monitor regularly. - Drug interaction review: assess concomitant medications for potential efficacy reduction. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Mercilon can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may reduce contraceptive efficacy. - Rifampicin and other strong CYP3A4 inducers: can markedly lower hormone levels. - St. John's wort: herbal inducer that may compromise birth control.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole): may increase plasma hormone concentrations. - Certain antiretrovirals (e.g., protease inhibitors): may elevate risk of thrombotic events.